This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Synopsys (SNPS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Synopsys (SNPS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Why Synopsys (SNPS) Outpaced the Stock Market Today
by Zacks Equity Research
Synopsys (SNPS) reachead $546.38 at the closing of the latest trading day, reflecting a +1.42% change compared to its last close.
How Should You Play Cadence (CDNS) Stock Post Q2 Earnings?
by Vaishali Doshi
Increasing design activity and opportunities from rapid AI proliferation bode well for Cadence (CDNS). However, competition and significant exposure to the semiconductor vertical is a concern.
Top Analyst Reports for SAP, Abbott Laboratories & Citigroup
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), Abbott Laboratories (ABT) and Citigroup Inc. (C), as well as two micro-cap stocks Team, Inc. (TISI) and Vaso Corporation (VASO).
Synopsys (SNPS) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Synopsys (SNPS) closed at $588.33 in the latest trading session, marking a +0.11% move from the prior day.
Manhattan Associates (MANH) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Manhattan Associates (MANH) delivered earnings and revenue surprises of 22.92% and 3.61%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Cadence Design Systems (CDNS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cadence (CDNS) delivered earnings and revenue surprises of 4.07% and 1.17%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Synopsys' (SNPS) Automotive IP Gets SGS-TUV Saar Certification
by Zacks Equity Research
Synopsys' (SNPS) ARC HS4xFS Processor IP chip gets the ISO/SAE 21434 grade certification by Swiss-German testing, inspection and certifying organization, SGS-TUV Saar.
Should You Buy Cadence (CDNS) Stock Ahead of Q2 Earnings?
by Vaishali Doshi
Cadence's (CDNS) Q2 performance is likely to have benefited from higher customer demand. Weak global macroeconomic conditions and stiff competition are concerning.
Synopsys (SNPS) Laps the Stock Market: Here's Why
by Zacks Equity Research
Synopsys (SNPS) closed the most recent trading day at $616.01, moving +0.32% from the previous trading session.
Brokers Suggest Investing in Synopsys (SNPS): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Synopsys (SNPS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Synopsys (SNPS) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Synopsys (SNPS) settling at $607.94, representing a -1.23% change from its previous close.
The Zacks Analyst Blog Highlights Applied Materials, Comcast, Synopsys and Hamilton Beach Brands
by Zacks Equity Research
Applied Materials, Comcast, Synopsys and Hamilton Beach Brands are included in this Analyst Blog.
Top Stock Reports for Applied Materials, Comcast & Synopsys
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Applied Materials, Inc. (AMAT), Comcast Corporation (CMCSA) and Synopsys, Inc. (SNPS), as well a micro-cap stock Hamilton Beach Brands Holding Company (HBB).
Why Is Salesforce.com (CRM) Up 16% Since Last Earnings Report?
by Zacks Equity Research
Salesforce.com (CRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synopsys (SNPS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Synopsys (SNPS) closed at $595, marking a -0.59% move from the previous day.
Synopsys, Inc. (SNPS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Synopsys (SNPS) Expands Its AI-based Multi-Die Portfolio
by Zacks Equity Research
Synopsys (SNPS) strengthens its position in chip manufacturing through the release of production-ready multi-die reference flow for Intel's chip foundry with AI-based systems integrated into it.
Wall Street Bulls Look Optimistic About Synopsys (SNPS): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Synopsys (SNPS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Why Is Synopsys (SNPS) Up 4.1% Since Last Earnings Report?
by Zacks Equity Research
Synopsys (SNPS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synopsys, Inc. (SNPS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Synopsys (SNPS). This makes it worthwhile to examine what the stock has in store.
Synopsys' (SNPS) PCIe 7.0 to Address AI Workload Data Bottlenecks
by Zacks Equity Research
Synopsys' (SNPS) innovative PCIe 7.0 IP solution is designed to enhance data transfer speeds and efficiency, addressing a critical bottleneck in AI and HPC environments.
Synopsys, Inc. (SNPS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Synopsys (SNPS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The Zacks Analyst Blog Highlights Walt Disney, Charles Schwab, Synopsys and HF Foods
by Zacks Equity Research
Walt Disney, Charles Schwab, Synopsys and HF Foods are part of the Zacks top Analyst Blog.
Top Research Reports for Walt Disney, Charles Schwab & Synopsys
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Company (DIS), The Charles Schwab Corporation (SCHW) and Synopsys, Inc. (SNPS), as well as a micro-cap stocks HF Foods Group Inc. (HFFG).